Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Kidney Neoplasms 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1

Interventions

X-Rays 6Cyclophosphamide 6Specimen Handling 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Nuclear Medicine Department, Hospital 4Biopsy 4fludarabine 3Gemcitabine 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2olaparib 2mifamurtide 2larotrectinib 2ivosidenib 2fludarabine phosphate 2ensartinib 2cabozantinib 2Methotrexate 2Mesna 2Ifosfamide 2Eflornithine 2Cisplatin 2trastuzumab deruxtecan 1tazemetostat 1talazoparib 1selinexor 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Blood Component Removal × 30 days × Clear all
NCT07428993 2026-05-19

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

St. Jude Children's Research Hospital

Phase 2 Recruiting
41 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡